EXELIXIS DIACHEIRISI EREVNAS KAI EPIKOINONIA EE

Their core work

Exelixis is a Greek SME specializing in research project management and communication services for EU-funded consortia. Their company name literally translates to "Research Management and Communication," and their project portfolio confirms this role — they participate across wildly diverse scientific domains (autoimmune diseases, 2D materials, cancer diagnostics, cardiovascular research) where a single SME would not hold deep technical expertise. Instead, they provide the management backbone and dissemination infrastructure that keeps multi-partner research projects running smoothly. Their value lies in handling communication, outreach, and administrative coordination so that scientists can focus on the science.

What they specialise in

How they've shifted over time

In their early H2020 period (2017-2018), Exelixis joined a broad mix of projects including autoimmune disease cohorts (HarmonicSS), asthma therapy (CURE), and advanced materials (LEAF-2D), establishing themselves as a versatile project support partner. By 2018-2020, their newer projects shifted toward biomedical diagnostics and complex health data — cancer detection via Raman spectroscopy (SENSITIVE) and immune-metabolic cardiovascular research (TO_AITION). This suggests they are building deeper roots in health research consortia while maintaining their horizontal service model.

Exelixis is gravitating toward health and biomedical research projects with complex data components, making them an increasingly experienced support partner for health-sector consortia.

How they like to work

Exelixis operates exclusively as a participant — never as coordinator — which is typical for project management and communication SMEs that serve consortia in a support capacity. With 66 unique partners across just 5 projects, they integrate into large, diverse consortia rather than small focused teams. Their broad partner network suggests they are reliable joiners who add value through management and dissemination rather than scientific leadership.

Despite only 5 projects, Exelixis has built a network of 66 unique partners across 17 countries, reflecting their role in large pan-European consortia. Their reach is genuinely European with no apparent geographic concentration beyond their Greek base.

What sets them apart

Exelixis fills a specific niche as a Greek SME providing research management and communication services to EU consortia, particularly in the health sector. For consortium builders, their value is practical: they handle the non-scientific workload — dissemination plans, communication deliverables, project administration — that research institutions often struggle with. Their growing concentration in health projects means they understand the sector's specific communication and regulatory requirements.

Highlights from their portfolio

• TO_AITION
  Their largest funded project (EUR 249,812) and most recent, focused on cardiovascular-depression immune-metabolic links — signals their current strategic direction in complex health research.
• SENSITIVE
  Cancer detection project combining Raman spectroscopy with endoscopic techniques, representing their involvement in advanced diagnostic technology consortia.
• HarmonicSS
  Their first H2020 project, involving big data mining across international Sjögren syndrome cohorts — established their entry into data-intensive health research.